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EDITORIAL
A plethora of epidermal growth factor–like proteins
in polycystic kidneys
One of the first abnormalities described in cell biologi-
cal studies of polycystic kidney disease pathogenesis was
the abnormal apical plasma-membrane localization of the
epidermal growth factor receptor (EGFR) in cyst lining
epithelial cells, as opposed to the normal localization in
mature kidneys on the basal membranes of proximal and
nephron tubule segments [1].
Subsequent studies found this to be an extremely
common feature of cystic kidney diseases, being ob-
served not only in human adult autosomal-dominant
(ADPKD) and autosomal-recessive polycystic kidney
diseases (ARPKD), but also in a variety of spontaneously
occurring autosomal-recessive mouse models of cystic re-
nal disease (cpk, bpk,), as well as mouse models derived
by targeted mutations of the PKD1 or PKD2 genes re-
sponsible for ADPKD and in genes that inhibit kidney
ciliogenesis (KIF3A and orpk) [2–4].
In addition, early studies suggested abnormalities in
EGF receptor species, number of molecules, hyperphos-
phorylation, and hyperactivity with regard to prolifera-
tive induction of epithelia in human ADPKD cells in vitro
and in vivo [1], as well as in ARPKD mice. Importantly,
both genetic manipulation and EGF receptor tyrosine
kinase inhibition have been shown to reduce cyst forma-
tion in mice, rats, and in human ADPKD cells in culture
[5, 6].
Because the EGF ligand was a well-known mitogen
for renal epithelia, and had been shown to exert hy-
perprolferative activity on human and mouse ADPKD
and ARPKD cystic epithelia in vitro, it was suggested
that the accessibility of apical EGF receptor to cyst
luminal EGF ligand could provide a mechanism for
autocrine/paracrine stimulation of proliferation in cys-
tic epithelia [7]. This was subsequently confirmed by
identification of EGF and EGF-reactive peptide species
secreted into the apical medium of cultured ADPKD ep-
ithelia, and even more compellingly by their detection in
high, potentially mitogenic concentrations in cyst fluids
collected from ADPKD patients [1].
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Although studies in mice with ARPKD confirmed sim-
ilar EGF/EGFR abnormalities associated with cyst for-
mation [3, 8], it soon became clear that other EGF-like
ligands and receptors might also play important roles.
For instance, during the developmental period, when
ARPKD cysts form, although renal EGF receptor levels
are high, levels of EGF ligand are low, but transforming
growth factor (TGF)-a are levels are high [9]. In addition,
transgenic mice overexpressing TGFa develop cystic kid-
neys [10].
An important article in this issue of Kidney Interna-
tional by MacRae Dell et al [11] helps to clarify this
seemingly confusing state of affairs by systematically
comparing and contrasting the roles of additional EGF-
like ligands in the bpk mouse model of mouse ARPKD.
Not only do the authors elucidate a hitherto unrecog-
nized role for heparin-binding EGF-like growth factor
(HB-EGF), but they also shed light on differing specifici-
ties and relative contributions of EGF ligands with regard
to cyst formation.
There are five known members in the EGF ligand fam-
ily of proteins: EGF, TGFa, HB-EGF, amphiregulin, and
betacellulin, all of which exert their proliferative effects
via phosphorylation of the cell membrane EGF receptor
dimers. They are all expressed in the developing kidney:
HB-EGF in the proximal tubule, EGF in thick ascend-
ing limb of Henle’s loop and distal convoluted tubule
(DCT), and TGFa in the DCT and collecting ducts. The
EGF receptor is expressed in every nephron segment.
The EGF ligands are synthesized as large preproforms
that are inserted into cell membranes as proforms and
then become cleaved by metalloproteases to derive small
(approximately 5 to 6 kD) soluble active proliferative fac-
tors. Transactivation of the EGF receptor by soluble EGF,
TGFa, HB-EGF, and amphiregulin have all been shown
to promote MAP kinase activation, and to be part of the
regulatory system that modulates cell migration and mi-
togenesis, whereas the membrane-bound proforms have
demonstrated roles in branching morphogenesis of the
developing kidney [12, 13].
MacRae Dell et al now describe results that suggest po-
tential mechanisms regulating the different specificities of
the EGF-like ligands. Although EGF, TGFa, HB-EGF,
and amphiregulin were all mitogenic to cystic > control
epithelia, HB-EGF showed the most marked activation
of EGF receptor (> EGF = TGFa > amphiregulin), and
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was seen on apical membranes of cystic epithelia, while
amphiregulin was not. In addition, immunoprecipitation
of EGF and TGFa, but not HB-EGF or amphiregulin
was able to significantly reduce the mitogenicity of cyst
fluids. Taken together, these studies suggest that the rel-
ative potencies of growth factors in the context of cyst
expansion are a function of membrane receptor and lig-
and trafficking, as well as ligand availability.
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